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Background and purpose: Subarachnoid hemorrhage is sometimes difﬁcult to diagnose radio-
logically. Cerebrospinal ﬂuid (CSF) ferritin has been proposed to be highly speciﬁc and sensitive
to detect hemorrhagic central nervous system (CNS) disease. We analyzed here the speciﬁcity
of CSF ferritin in a large series of various CNS diseases and the inﬂuence of serum ferritin.
Materials and methods: CSF ferritin, lactate, protein and total cell count were analyzed in 141
samples: neoplastic meningitis (n = 62), subarachnoid hemorrhage (n = 20), pyogenic infec-
tion (n = 10), viral infection (n = 10), multiple sclerosis (n = 10), borreliosis (n = 5) and normal
controls (n = 24). Cerebrospinal ﬂuid ferritin was measured with a microparticle immuno-
assay. In addition, serum and CSF ferritin were compared in 18 samples of bacterial and
neoplastic meningitis.
Results: In CNS hemorrhage, median ferritin was 51.55 mg/L (sensitivity: 90%) after the
second lumbar puncture. In neoplastic meningitis, the median CSF ferritin was 16.3 mg/L
(sensitivity: 45%). Interestingly, ferritin was higher in solid tumors than that in hematologi-
cal neoplasms. In 90% of pyogenic inﬂammation, ferritin was elevated with a median of
53.35 mg/L, while only 50% of patients with viral infection had elevated CSF ferritin. In
ventricular CSF, median ferritin was 163 mg/L, but only 20.6 mg/L in lumbar CSF. Ferritin was
normal in multiple sclerosis and borreliosis.
Conclusions: Ferritin was elevated not only in hemorrhagic disease, but also in neoplastic and
infectious meningitis. Ferritin was not a reliable marker of the course of disease. The
inﬂuence of serum ferritin on CSF ferritin is negligible. We conclude that elevated CSF
ferritin reliably, but unspeciﬁcally indicates severe CNS disease.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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In spite of improvements of computed and magnetic resonance
tomography, the diagnosis of hemorrhage affecting the central* Corresponding author at: Department of Neurosurgery, University of
E-mail address: malgorzata.kolodziej@neuro.med.uni-giessen.de (M
0028-3843/$ – see front matter # 2014 Polish Neurological Society. Pu
http://dx.doi.org/10.1016/j.pjnns.2013.09.004nervous system (CNS) still remains difﬁcult in a number of
cases, especially when performed more than 6 days after
disease onset [1]. Thus, cerebrospinal ﬂuid (CSF) ferritin may be
an important biomarker to indicate hemorrhage that reaches
the inner or outer CSF spaces. Previous studies reported a high Giessen, Klinikstr. 33, 35385 Giessen, Germany.
.A. Kolodziej).
blished by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Fig. 1 – Comparison of ferritin concentrations in all
diagnostic groups. Center line, median; boxes, 25 and 75%
percentiles; vertical lines, total range of values.
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We asked here if ferritin was a suitable marker to discriminate
CNS hemorrhage from bacterial and neoplastic meningitis and
other acute or subacute diseases of the CNS.
The iron-binding protein ferritin occurs in 20 isoferritin
variants in each organ, mainly in liver, spleen and bone
marrow. After hemorrhagic events, most tissues synthesize
ferritin in order to bind free iron and prevent the occurrence of
free radicals that damage tissues. In addition to tissue-
building cells, macrophages are among the most potent
synthesizers of ferritin. When the excess of iron is too high
to be bound, cells are lyzed and ferritin released which can be
measured in the surrounding body ﬂuid [2,10]. Ferritin levels in
different organs correlate with serum ferritin and are elevated
not only in cases of hemorrhage, but also in malignant disease
[11], and acute or chronic inﬂammation [12].
Serum ferritin increases in hematological and solid
neoplasms, such as hepatocellular carcinoma, pancreatic
cancer, lung cancer and neuroblastoma. It correlates with
tumor activity and dissemination. Tumor-associated increase
of serum ferritin is caused by ferritin synthesis by tumor cells
[13] and tumor-tissue disbanding [6].
With its high molecular weight of 450 kD, ferritin does not
cross the blood–brain-barrier [3]; yet it is also detected in the
CSF of healthy individuals. The physiological level of ferritin in
the CNS depends on the iron level in CSF oligodendroglia [14].
Following CNS hemorrhage, ferritin in the CSF increases
especially in microglial cells. Ferritin is also one of the
immunohistochemical markers of microglia [15].
The standard range of ferritin in the CSF has not yet been well
deﬁned. Milman et al. [3] assumed a normal range of CSF ferritin
to 2–7 mg/L, Sindic et al. [6] set an upper limit at 5.5 mg/L, and
Zappone [9] – at 20 mg/L. In our clinical routine, the upper limit is
set at 18 mg/L, according to the publication of Kern et al. [16].
With this relatively high upper limit of CSF ferritin, we
assessed the sensitivity and speciﬁcity of this surrogate marker
in cases of CNS hemorrhage and compared with cases of viral
and pyogenic (bacterial and fungal) infection, neoplastic
meningitis, multiple sclerosis and controls without pathological
CSF ﬁndings.
2. Materials and methods
A total of 141 CSF samples were evaluated retrospectively and
in part prospectively. The cases were divided into diagnosticTable 1 – Rate of elevated ferritin, median level, total range, an
indicated by p-values. The p-value indicates the level of signif
(Mann–Whitney U-test).
Disease n CSF ferritin median (mg/L
Control group 24 9.45 
Hemorrhage 20 51.55 
Neoplastic meningitis 62 16.25 
Bacterial meningitis 10 53.35 
Viral meningitis 10 18.85 
Neuroborreliosis 5 7.5 
Multiple sclerosis 10 6.15 
CSF, cerebrospinal ﬂuid.groups: normal-pressure-hydrocephalus (NPH, n = 24) as a
control group without pathological CSF examination, sub-
arachnoid hemorrhage (n = 20), neoplastic meningitis (n = 62),
bacterial meningitis (n = 10), viral meningitis (n = 10), borre-
liosis (n = 5) and multiple sclerosis (n = 10). Cerebrospinal ﬂuid
levels of ferritin, lactate, total protein and total cell count were
determined in our laboratory between 1999 and 2006. In
addition, ferritin was measured in 18 paired serum/CSF
samples (bacterial meningitis – 5 cases, hemorrhage – 6 cases,
gliomas – 2 cases, as well as trauma, amyotrophic lateral
sclerosis and headache one each) in order to assess a possible
inter-correlation.
Cerebrospinal ﬂuid ferritin was measured with a micro
particle enzyme immunoassay (MEIA) AxSYM ABBOTT in
undiluted CSF samples. 200 mL of CSF sample was required.
The analytic sensitivity of the AxSYM ferritin assay was
1.0 ng/mL.
Cerebrospinal ﬂuid total protein was quantiﬁed by a
turbidimetric method of sulphosalicylic acid and CSF glucose
was quantiﬁed with an enzymatic method. Cerebrospinal ﬂuid
total cells were counted microscopically in a Fuchs Rosenthal
chamber by an experienced technician. For differential cell
count and to detect the presence of malignant cells, CSF
samples were concentrated by Cytospin. Cerebrospinal ﬂuid
samples were protein-enriched with albumin. The slides wered difference from controls in the diagnostic groups as
icance for the difference of ferritin from the control group
) Limit (mg/l) Values > 18 mg/L p-Value
18 0 <0.001
18 15 (75%)
18 27 (45%) 0.022
18 9 (90%) 0.75
18 5 (50%) 0.070
18 0 0.001
18 1 (10%) <0.001
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at least two trained researchers (SMA and EN). Cerebrospinal
ﬂuid samples with more than 50 erythrocytes/mm3 were
excluded.
2.1. Statistical analyses
The correlation between CSF ferritin and the underlying
disease was analyzed with the Kruskal– Wallis test, the
Mann–Whitney U-test and the x2 test.
3. Results
3.1. Diagnostic groups
In the control group, median ferritin was 9.45 mg/L. All ferritin
levels were lower than 18 mg/L (Fig. 1 and Table 1).
In patients with CNS hemorrhage, ferritin was increased
above 18 mg/L in 15/20 (75%) patients in the ﬁrst CSF probe. The
median ferritin was 51.55 mg/L and signiﬁcantly higher than
that in the control group ( p < 0.001; total range 10.8–2170 mg/L,
Fig. 1 and Table 1). In consecutive examinations, additional
15% of patients had increased ferritin levels.
Differences were seen between lumbar and ventricular
ferritin. The median value of ferritin in the ventricular CSF was
163 mg/L, while the median lumbar ferritin was only 20.6 mg/L.
In neoplastic meningitis, 28/62 (45%) patients had increased
CSF ferritin levels with a median of 16.3 mg/L (total range 2.3–
792 mg/L, not signiﬁcant). Interestingly, ferritin levels were
higher in neoplastic meningitis from solid tumors (median
17.3 mg/l) than that in hematological neoplasms (12.5 mg/l). The
second lumbar puncture revealed additional 10% of cases with
elevated ferritin. The median CSF lactate was not elevated, and
the intraindividual values did not correlate with CSF ferritin
levels.
The highest median ferritin of 53.35 mg/L was found in
pyogenic (bacterial and fungal) meningitis, where 9/10 (90%) of
patients had elevated ferritin (total range 14.5–542 mg/L). In
viral meningitis, only 5 of 10 patients had elevated CSF ferritin
and the median ferritin was only slightly elevated to 18.85 mg/L
(total range 3.9–343 mg/L). No elevated values and no increase
of median CSF ferritin were seen in patients with borreliosis or
multiple sclerosis.
3.2. Comparison between diagnostic groups
The Mann–Whitney U-test, but not the x2 test, showed that CSF
ferritin was signiﬁcantly higher in cases of hemorrhage as
compared with neoplastic meningitis ( p = 0.022, Table 2).
Levels of CSF ferritin were comparable in hemorrhage and
bacterial meningitis. The group of patients with viral inﬂam-
mation showed an insigniﬁcant tendency to lower levels of
CSF ferritin in comparison with the hemorrhage group
( p = 0.070, Kruskal–Wallis; p = 0.338, x2 test).The frequency of
distribution of CSF ferritin as assessed with the Mann–
Whitney U-test varied in all groups; only the groups of viral
inﬂammation and of neoplastic meningitis had similar
distribution ( p = 0.657). The median value was 22.9 mg/L for
the neoplastic meningitis patients and 18.85 mg/L for viral
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 1 6 – 1 2 1 119inﬂammation. Taken together, ferritin levels in hemorrhagic
disease were not signiﬁcantly higher than that in pyogenic
infection or in neoplastic meningitis.
In the group of patients with bacterial meningitis, 2/10
patients had elevated serum (and CSF) ferritin levels.
Furthermore, only one patient in the neoplastic meningitis
group (1/10) showed a higher level of ferritin in the serum,
while CSF ferritin was normal.
4. Discussion
The study presented here analyzed lumbar and ventricular
CSF ferritin in hemorrhagic and non-hemorrhagic disease
compared with normal controls without known pathology.
Lumbar CSF ferritin was most often increased in the second
sample in hemorrhagic disease with a high sensitivity of 90%.
We found, however, signiﬁcantly elevated CSF ferritin also in
neoplastic and infectious meningitis.
Ferritin as an iron-binding protein that does not cross the
blood–brain barrier is most often regarded to be an indicator of
hemorrhagic CNS disease. We observed an elevated level of
ferritin in serum and CSF at the same time in 3 cases only. In
line with previous reports [2–4,6–9], we found signiﬁcantly
elevated ferritin levels following subarachnoid and intracere-
bral hemorrhage. Interestingly, 25% (2/8) of the results in
samples taken up to 3 days after disease onset were false-
negative, which resulted in a total of 15% false-negative results
in the ﬁrst samples. Only 1/17 (6%) false-negative results was
assessed between 4 and 20 days after the bleeding, leading to a
sensitivity of 90% when a second sample was taken in case of a
negative ﬁrst result. In none of the 3 (100%) samples taken 30 or
more days after hemorrhage, CSF ferritin was increased,
indicating a complete normalization within this time. Accord-
ingly, a maximum of CSF ferritin levels between day 4 and 6
after hemorrhage has been reported previously [2]. Apparent-
ly, ferritin does not increase before phagocytosis of erythro-
cytes or hemosiderin can be detected cytologically, which is
assumed to be the case within 12–24 h [17–21]. Cerebrospinal
ﬂuid ferritin analysis may therefore be regarded as equally
quick and sensitive but unspeciﬁc, while the detection of
siderophages is highly speciﬁc for CNS hemorrhage [22–25].
Of note, ferritin was signiﬁcantly higher in ventricular than
that in lumbar samples. This is most probably an epiphenom-
enon, since ventricular samples were taken through external
drains, which are necessary only in severe intracranial
bleeding. Unfortunately, we could not compare lumbar and
ventricular samples in the same patient at the same time,
since there was no need for a lumbar puncture once a
ventricular drainage was applied.
Although associated with a high sensitivity, CSF ferritin
cannot be regarded as speciﬁc for CNS hemorrhage, since
signiﬁcantly elevated levels are also observed in neoplastic
and infectious meningitis [26]. Controls or cases of multiple
sclerosis were not associated with elevated CSF ferritin.
Thus, CSF ferritin has to be regarded as an unspeciﬁc
marker of severe CNS pathology, which excludes normal
conditions within the CNS. This corresponds to reports from
other groups who also found elevated ferritin in these
diseases [3,6,9,16,27–29].The gold standard for the diagnosis of neoplastic meningi-
tis is CSF cytology [30]. In malignant disease, serum ferritin can
be elevated through synthesis by tumor cells [13,31] or by
tissue lysis [6]. In neoplastic meningitis, an elevation of CSF
ferritin has been described previously [9,13,16,29]. Cerebrospi-
nal ﬂuid ferritin was even proposed to be an early marker of
malignant CSF involvement [9,13]. In the study presented here,
there was only one case of ferritin elevation previous to the
cytological detection of malignant cells. The overall sensitivi-
ty, however, was only 45%. This may be explained by the fact
that one-third of the cases with cytologically proven neoplas-
tic meningitis had normal cell counts. Total cell count was
signiﬁcantly correlated with CSF ferritin in the initial analysis
of this group, but not in subsequent samples. Interestingly,
ferritin levels in NM from hematological malignancies were
not signiﬁcantly higher than normal controls. These ﬁndings
may explain that the sensitivity in our series was lower than
that in other series which found sensitivities of 69% [29] or
even 90% [16]. Taken together, CSF ferritin only occasionally
indicates NM in cases of normal cell counts and negative
cytology and is not reliable as an early marker of neoplastic
meningitis. Although a decrease of ferritin levels after
successful intrathecal chemotherapy could be observed in
some of our patients, increasing levels were seen in other
cases in spite of normalized routine CSF analysis. This makes
the value of ferritin as a marker of response of NM to treatment
most doubtful.
Inﬂammatory processes are often associated with necrotic
cell death. This may be more pronounced in pyogenic than in
lymphocytic infection. The release of ferritin by necrotic cell
death may be the source of elevated CSF levels found in
infectious disease. In line with other studies [3,6,9,10,13,16,29],
CSF ferritin was elevated in 90% of pyogenic (including one
fungal) and 50% of viral infections. By contrast, no case of CNS
borreliosis was associated with high ferritin levels. Also in
chronic inﬂammatory CNS disease and multiple sclerosis, no
elevation of ferritin was detected. This indicates that ferritin is
associated with more severe inﬂammation. Nevertheless, no
correlation between total cell count as an indicator of CNS
inﬂammation and ferritin levels was found. Although multiple
sclerosis is a disease with loss of mainly oligodendroglial cells
which contain a considerable amount of CNS ferritin, no
increase of CSF ferritin values was observed. Obviously,
oligodendroglial loss is slow enough to enable the cleavage
of ferritin from the CSF.
Although a number of patients with degenerative disease
were included into the control group, no increase of CSF
ferritin was seen. In one previous series, no pathological
values were found as well [9], while two other studies
occasionally found elevated ferritin [6,16]. Obviously, also in
degenerative disease the loss of CNS cells is slow enough to
allow for cleavage of ferritin from the CSF.
5. Conclusions
The negative predictive value of normal CSF ferritin values is
not sufﬁcient to exclude CNS disease. By contrast, elevated CSF
ferritin regularly, but unspeciﬁcally indicates severe CNS
disease like hemorrhage, neoplastic disease or infection. Of
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 1 6 – 1 2 1120note, ferritin may take 2–4 days to be elevated and can be false-
negative when examined too early. In this series, ferritin was
not suitable to monitor the response of neoplastic meningitis
to treatment. By such, ferritin may be helpful as an additional
diagnostic marker, but always has to be considered in the
context of clinical picture and routine CSF analysis.
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